Bovine Pericardium Membrane Versus Native Collagen Membrane in Conjunction With Sticky Bone Graft in Treatment of Class II Furcation Defects in Lower Molars.
1 other identifier
interventional
20
1 country
1
Brief Summary
Materials and methods: Twenty five patients (n=25) were selected from the outpatient clinic of the department of oral medicine and periodontology at Mansoura university's faculty of dentistry, 5 patients (n=5) were excluded as they didn't meet the inclusion criteria or met one or more of the exclusion criteria. The participants 20 patients exhibiting one buccal or lingual mandibular molar furcation defect were assigned into two treatment groups: group I (control group), group II (study group), 10 patients in each group. Patients in group I will be treated with open flap debridement, native collagen membrane and bovine bone graft particles. Patients in group II will be treated with open flap debridement, bovine pericardium membrane and bovine bone graft particles. Periodontal assessment (plaque index (PI), gingival index (GI), horizontal clinical attachment level (HCAL), vertical clinical attachment level (VCAL), gingival recession (REC) and probing depth (PD)) will be evaluated at baseline, 3 months and 6 months after periodontal treatment. Radiographic assessment using CBCT (bone loss in the horizontal direction (BL-H), bone loss in vertical direction (BL-V), length of the root trunk (RT), width of furcation entrance (FW) will be evaluated at baseline and 6 months after periodontal treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
November 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJanuary 8, 2026
January 1, 2026
1.4 years
November 1, 2024
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Clinical ( Horizontal clinical attachment level [HCAL] )
Is measured with Naber's probe, measure the depth of Furcation.
6 months
Radiographic ( Bone loss in the horizontal direction [BL-H] )
Using the CBCT axial view to measure the distance between the outer root surface and the inter-radicular bone.
6 months
Study Arms (2)
Control group
ACTIVE COMPARATORAre treated with open flap debridement, native collagen membrane and bovine bone graft particles.
Study group
EXPERIMENTALAre treated with open flap debridement, bovine pericardium membrane and bovine bone graft particles.
Interventions
The bovine bone graft particles will be mixed with concentrated growth factor (CGF) to form sticky bone, the furcation defect area will be condensed with the mixture and covered completely with native collagen membrane.
the bovine bone graft particles will be mixed with concentrated growth factor (CGF) to form sticky bone, the furcation defect area will be condensed with the mixture and covered completely with bovine pericardium membrane.
Eligibility Criteria
You may qualify if:
- Display a buccal or lingual class II furcation defect (Hamp et al. classification) in their lower molars.
- The tooth with a horizontal clinical attachment level (HCAL) greater than 3mm and a probing depth (PD) greater than or equal to 6mm in the mid-buccal or mid-lingual sites.
- Have not undergone any periodontal treatment in the past 6 months.
- A plaque index score (PI) below 1 at surgery, assessed using the Ramfjord teeth.
You may not qualify if:
- Patients with class I or class III furcation defects.
- Systemic disease contraindicating periodontal surgery.
- Taking any medication that may have an impact on their periodontal health within the last 6 months.
- Smoking.
- Being pregnant or lactating.
- Teeth with periapical lesions and teeth with mobility.
- Third molars or teeth with improper endodontic or restorative treatment.
- Patients with furcation caries, metal crowns in the furcation area or amalgam fillings near the alveolar crest.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of dentistry , Mansoura university
Al Mansurah, Dakahlia Governorate, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ibrahim A Zein Elabdin
Mansoura university Faculty of dentistry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- BDS, Principal Investigator, Oral Medicine, and Periodontology Department.
Study Record Dates
First Submitted
November 1, 2024
First Posted
November 8, 2024
Study Start
September 1, 2024
Primary Completion
February 1, 2026
Study Completion
March 1, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01